Daisuke Honda

863 total citations
30 papers, 609 citations indexed

About

Daisuke Honda is a scholar working on Genetics, Nephrology and Rheumatology. According to data from OpenAlex, Daisuke Honda has authored 30 papers receiving a total of 609 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Genetics, 13 papers in Nephrology and 10 papers in Rheumatology. Recurrent topics in Daisuke Honda's work include Coagulation, Bradykinin, Polyphosphates, and Angioedema (15 papers), Urticaria and Related Conditions (6 papers) and Parathyroid Disorders and Treatments (6 papers). Daisuke Honda is often cited by papers focused on Coagulation, Bradykinin, Polyphosphates, and Angioedema (15 papers), Urticaria and Related Conditions (6 papers) and Parathyroid Disorders and Treatments (6 papers). Daisuke Honda collaborates with scholars based in Japan, Australia and Denmark. Daisuke Honda's co-authors include Masaki Otagiri, Yu Ishima, Masafumi Fukagawa, Shokei Kim‐Mitsuyama, Qiong Wu, Toru Maruyama, Motoko Tanaka, Keiichiro Kataoka, Yohei Miyamoto and Tsuyoshi Noguchi and has published in prestigious journals such as Kidney International, Journal of Allergy and Clinical Immunology and Journal of the American Society of Nephrology.

In The Last Decade

Daisuke Honda

26 papers receiving 598 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daisuke Honda Japan 12 266 213 138 92 89 30 609
HE Li-qun China 15 279 1.0× 215 1.0× 39 0.3× 34 0.4× 59 0.7× 56 666
Ruixia Sun China 14 365 1.4× 321 1.5× 69 0.5× 73 0.8× 164 1.8× 34 909
Xinli Xu China 9 322 1.2× 246 1.2× 18 0.1× 87 0.9× 51 0.6× 12 690
Juan Jin China 15 234 0.9× 367 1.7× 55 0.4× 41 0.4× 63 0.7× 56 808
Xianjin Bi China 15 296 1.1× 268 1.3× 17 0.1× 57 0.6× 53 0.6× 18 649
Yanlin Yu China 11 242 0.9× 187 0.9× 16 0.1× 64 0.7× 45 0.5× 15 550
Shirong Cao United States 15 240 0.9× 254 1.2× 21 0.2× 52 0.6× 38 0.4× 23 690
In Jin Kim South Korea 15 170 0.6× 199 0.9× 30 0.2× 40 0.4× 84 0.9× 31 648
Kameswaran Ravichandran United States 18 274 1.0× 507 2.4× 28 0.2× 46 0.5× 264 3.0× 25 1.1k
Xiaomin Pan United States 10 26 0.1× 164 0.8× 78 0.6× 67 0.7× 37 0.4× 16 574

Countries citing papers authored by Daisuke Honda

Since Specialization
Citations

This map shows the geographic impact of Daisuke Honda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daisuke Honda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daisuke Honda more than expected).

Fields of papers citing papers by Daisuke Honda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daisuke Honda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daisuke Honda. The network helps show where Daisuke Honda may publish in the future.

Co-authorship network of co-authors of Daisuke Honda

This figure shows the co-authorship network connecting the top 25 collaborators of Daisuke Honda. A scholar is included among the top collaborators of Daisuke Honda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daisuke Honda. Daisuke Honda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hamano, Takayuki, Fumihiko Koiwa, Yoshitaka Isaka, et al.. (2024). Long-Term Efficacy and Safety of Upacicalcet in Japanese Hemodialysis Patients with Secondary Hyperparathyroidism: Open-Label 52-Week Study. American Journal of Nephrology. 56(1). 1–15. 1 indexed citations
2.
3.
Shigematsu, Takashi, Fumihiko Koiwa, Yoshitaka Isaka, et al.. (2023). Efficacy and Safety of Upacicalcet in Hemodialysis Patients with Secondary Hyperparathyroidism. Clinical Journal of the American Society of Nephrology. 18(10). 1300–1309. 15 indexed citations
4.
Inaguma, Daijo, Fumihiko Koiwa, Masanori Tokumoto, et al.. (2023). Phase 2 study of upacicalcet in Japanese haemodialysis patients with secondary hyperparathyroidism: an intraindividual dose-adjustment study. Clinical Kidney Journal. 16(12). 2614–2625. 1 indexed citations
5.
Honda, Daisuke, Philip H. Li, Ankur Kumar Jindal, et al.. (2023). Uncovering the true burden of hereditary angioedema due to C1-inhibitor deficiency: A focus on the Asia-Pacific region. Journal of Allergy and Clinical Immunology. 153(1). 42–54. 12 indexed citations
6.
Kazama, Junichiro James, Fumihiko Koiwa, Keitaro Yokoyama, et al.. (2022). First-in-Patient Phase I/II Study of Upacicalcet in Japanese Patients with Secondary Hyperparathyroidism Undergoing Hemodialysis: Pharmacokinetic and Pharmacodynamic Properties. Clinical Pharmacokinetics. 61(9). 1271–1284. 8 indexed citations
7.
Koiwa, Fumihiko, et al.. (2022). First-in-Human Phase I Study of the Novel Injectable Calcimimetic Agent Upacicalcet in Healthy Adult Japanese Participants. Drugs in R&D. 22(2). 131–140. 6 indexed citations
8.
Ohsawa, Isao, Atsushi Fukunaga, Shinya Imamura, et al.. (2021). Survey of actual conditions of erythema marginatum as a prodromal symptom in Japanese patients with hereditary angioedema. World Allergy Organization Journal. 14(2). 100511–100511. 6 indexed citations
9.
Suzuki, Hitoshi, et al.. (2021). Atypical histological abnormalities in an adult patient with nephronophthisis harboring NPHP1 deletion: a case report. BMC Nephrology. 22(1). 261–261. 3 indexed citations
10.
Honda, Daisuke, et al.. (2021). A case of hereditary angioedema due to C1-inhibitor deficiency with recurrent abdominal pain diagnosed 40 years after the occurrence of the initial symptom. Clinical Journal of Gastroenterology. 14(4). 1175–1179. 2 indexed citations
11.
12.
Yamaguchi, Yu, et al.. (2020). Upacicalcet, a Novel Non-Peptide Calcimimetic for the Treatment of Secondary Hyperparathyroidism, Has a Low Risk of Hypocalcemia. Journal of the American Society of Nephrology. 31(10S). 148–148. 3 indexed citations
13.
Iwamoto, Kazumasa, Beverley Anne Yamamoto, Isao Ohsawa, et al.. (2020). The diagnosis and treatment of hereditary angioedema patients in Japan: A patient reported outcome survey. Allergology International. 70(2). 235–243. 22 indexed citations
14.
15.
Honda, Daisuke, Isao Ohsawa, Nobuyuki Sato, et al.. (2017). Diminished capacity of opsonization and immune complex solubilization, and detection of anti-C1q antibodies in sera from patients with hereditary angioedema. Allergology International. 66(4). 603–609. 5 indexed citations
16.
Ohsawa, Isao, et al.. (2015). Clinical manifestations, diagnosis, and treatment of hereditary angioedema: survey data from 94 physicians in Japan. Annals of Allergy Asthma & Immunology. 114(6). 492–498. 25 indexed citations
17.
Ohsawa, Isao, Nobuyuki Sato, Hiroyuki Inoshita, et al.. (2014). Properdin has an ascendancy over factor H regulation in complement-mediated renal tubular damage. BMC Nephrology. 15(1). 82–82. 14 indexed citations
18.
Watanabe, Hiroshi, Yohei Miyamoto, Daisuke Honda, et al.. (2013). p -Cresyl sulfate causes renal tubular cell damage by inducing oxidative stress by activation of NADPH oxidase. Kidney International. 83(4). 582–592. 306 indexed citations
19.
Ohsawa, Isao, Daisuke Honda, Nobuyuki Sato, et al.. (2013). Leukocytosis and high hematocrit levels during abdominal attacks of hereditary angioedema. BMC Gastroenterology. 13(1). 123–123. 21 indexed citations
20.
Iwao, Yasunori, Yu Ishima, Junji Yamada, et al.. (2012). Quantitative evaluation of the role of cysteine and methionine residues in the antioxidant activity of human serum albumin using recombinant mutants. IUBMB Life. 64(5). 450–454. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by HE Li-qun Breakdown of academic impact, for papers by Ruixia Sun Breakdown of academic impact, for papers by Xinli Xu Breakdown of academic impact, for papers by Juan Jin Breakdown of academic impact, for papers by Xianjin Bi Breakdown of academic impact, for papers by Yanlin Yu Breakdown of academic impact, for papers by Shirong Cao Breakdown of academic impact, for papers by In Jin Kim Breakdown of academic impact, for papers by Kameswaran Ravichandran Breakdown of academic impact, for papers by Xiaomin Pan
Rankless by CCL
2026